Gabapentin as Adjuvant for Postoperative Pain in Pediatric Orthopedic Surgery

Sponsor
Hospital Infantil Albert Sabin (Other)
Overall Status
Completed
CT.gov ID
NCT03005483
Collaborator
Fortaleza University (Other)
40
1
2
28
1.4

Study Details

Study Description

Brief Summary

This study is a clinical trial, prospective, randomized and double-blinded. Gabapentin oral 10 mg/kg was administered to reduce the pain intensity as well as the opioid consumption in children from 3 months to 16 years submitted unilateral limb surgery.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

This study is a clinical trial, prospective, randomized and double-blinded. Gabapentin oral 10 mg/kg was administered to reduce the pain intensity as well as the opioid consumption in children from 3 months to 16 years submitted unilateral limb surgery. The children were divided into 2 groups: the gabapentin group (GG) was administered gabapentin 1 to 2 hours before procedure (N-40) and the placebo group (GP) was administered placebo 1 to 2 hours before surgery (N-44). Both groups were subjected to the same general anesthesia protocol, opioid free, and femoral and sciatic block with bupivacaine 0.125%. All patients received dipyrone and rescue analgesic used was morphine into 2/2h. The variables studied were age, gender, weight, type of surgery, hemodynamics, postoperative pain and morphine consumption .

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Placebo Controlled, Randomized,Gabapentin as Adjuvant for Postoperative Pain in Pediatric Orthopedic Surgery
Study Start Date :
Jan 1, 2014
Actual Primary Completion Date :
Jan 1, 2015
Actual Study Completion Date :
May 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Gabapentin

Gabapentin 10 mg/kg in children submitted unilateral limb surgery

Drug: Gabapentin
Orthopedic Surgery was applied for the treatment of osseous disorders
Other Names:
  • Orthopedic Surgery
  • Placebo Comparator: Placebo

    Placebo in children submitted unilateral limb surgery

    Other: Placebo
    Orthopedic Surgery was applied for the treatment of osseous disorders

    Outcome Measures

    Primary Outcome Measures

    1. Reduce the pain intensity using the Face Pain Scale [24 hour]

      Subjected to the same general anesthesia protocol, opioid free, and femoral and sciatic block with bupivacaine 0.125%.The evaluation times were: 1 hour, 4 hours, 8 hours, 12 hours, 18 hours and 24 hours after surgery. The time elapsed was recorded, from the end of the surgery to the first use of morphine. The parents and the patients themselves were instructed to request analgesic at any time.

    Secondary Outcome Measures

    1. Reduce the opioid consumption through 24 hours postoperative observation [24 hour]

      Subjected to the same general anesthesia protocol, opioid free, and femoral and sciatic block with bupivacaine 0.125%. All patients received dipyrone and rescue analgesic used was administered morphine 50mcg / kg (maximum dose of 2mg) up to 2 / 2h when Face´s Scales reached 5 points.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Months to 16 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Children between 3 months and 16 years who were previously healthy submitted to unilateral lower limb surgery

    Exclusion Criteria:

    Children cardiac, pulmonary, renal and neurological diseases and allergy and refusal of parents, caregivers and patients to participate in the study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital Infantil Albert Sabin Fortaleza Ceara Brazil 60410794

    Sponsors and Collaborators

    • Hospital Infantil Albert Sabin
    • Fortaleza University

    Investigators

    • Study Chair: Josenília Gomes, PhD, Fortaleza University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    washington aspilicueta pinto filho, Medical Anesthesiologist, Hospital Infantil Albert Sabin
    ClinicalTrials.gov Identifier:
    NCT03005483
    Other Study ID Numbers:
    • HOSPITALIAS
    First Posted:
    Dec 29, 2016
    Last Update Posted:
    Dec 29, 2016
    Last Verified:
    Dec 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by washington aspilicueta pinto filho, Medical Anesthesiologist, Hospital Infantil Albert Sabin
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 29, 2016